Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROTHYM - Phase II Non-randomized Study on Proton Radiotherapy Of Thymic Malignancies

NCT04822077 is registered in ClinicalTrials.gov with Ass. Prof. Jan Nyman as lead sponsor.

NCT NCT04822077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04822077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROTHYM - Phase II Non-randomized Study on Proton Radiotherapy Of Thymic Malignancies
Lead sponsor
Ass. Prof. Jan Nyman
Phase
Not applicable
Overall status
Recruiting
Start date
April 18, 2018
Completion date
April 1, 2029
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, pulmonary toxicity, thymus neoplasms